Piclib 125mg Capsule

About Piclib 125mg Capsule

Piclib 125mg Capsule contains Palbociclib, a targeted anticancer medication that belongs to the cyclin-dependent kinase (CDK) 4/6 inhibitor class and is used in combination with hormonal therapies for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer. It works by blocking specific enzymes that promote cancer cell growth and division, helping to slow disease progression and improve treatment outcomes. Piclib 125mg Capsule is typically prescribed alongside other anticancer medications as part of a comprehensive breast cancer treatment plan. Common side effects may include nausea, vomiting, diarrhea, fatigue, hair thinning or hair loss, dry skin, rash, infections, nosebleeds, decreased appetite, low blood cell counts, mouth sores, changes in taste, dry eyes, blurred vision, and excessive tearing. Patients should inform their healthcare provider if any of these side effects persist or become severe. Before starting treatment, it is important to disclose any history of liver disease, kidney problems, ongoing infections, or sugar intolerance, as well as all prescription medicines, supplements, and herbal products being taken. Patients should seek immediate medical attention if they develop symptoms such as persistent dry cough, chest pain, or difficulty breathing, as these may indicate serious lung inflammation. Effective contraception should be used during treatment and for at least three weeks after the final dose to prevent pregnancy-related risks. Piclib 125mg Capsule is not recommended for children and adolescents under 18 years of age. Regular blood tests and medical monitoring are essential to ensure the safe and effective use of this medication in managing advanced breast cancer.